KCAT19 T cells
/ University College London
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 26, 2022
KCAT19: Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: University College, London
New P1 trial • Hematological Malignancies • Oncology • CD19
1 to 1
Of
1
Go to page
1